Medicines Co. (NASDAQ: MDCO) is down 9.1% after-hours after Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced that upon the recommendation of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Trader Talk

Jefferies Sees No Read-Through to The Medicines Company (MDCO) PCSK9 from Alnylam SetbackOctober 6, 2016 6:44 AM Leerink Partners Downgrades Alnylam Pharmaceuticals (ALNY) to Market PerformOctober 6, 2016 6:39 AM Medicines Co. (MDCO) Updtes on ORION-1 Study; Says IDMC Raised No Safety ConcernsOctober 5, 2016 4:37 PM The Medicines Company Provides Progress Update on Ongoing ORION-1 Study of PCSK9siOctober 5, 2016 4:35 PM Alnylam Pharma (ALNY) to Discontinue Development of Revusiran; Decision Will Not Affect PatisiranOctober 5, 2016 4:31 PM